Head and Neck Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Head and Neck
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | Alliance A092205 [JIT] |
|---|---|
| Cancer Type: | Head and Neck |
A Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Platinum Refractory Disease
| Protocol | NRG HN016 (JIT) |
|---|---|
| Cancer Type: | Head and Neck |
Protocol NRG-HN016, Radiotherapy with Concurrent Cetuximab vs. Carboplatin and Paclitaxel in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin: A Pragmatic Phase III Randomized Trial (CONCISE)
| Protocol | NRG HN015 (JIT) |
|---|---|
| Cancer Type: | Head and Neck |
NRG-HN015, A Phase II Randomized Trial of Neoadjuvant Chemotherapy or Chemo-Immunotherapy in Patients with Recurrent/Persistent PD-L1 Enriched Squamous Cell Carcinoma of the Head and Neck Undergoing Salvage Surgery (NEOPOLIS)
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | EA3132 |
|---|---|
| Cancer Type: | Head and Neck |
| Fast Facts |
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG HN010 [JIT] |
|---|---|
| Cancer Type: | Salivary Gland |
A CONTROLLED, RANDOMIZED PHASE II TRIAL OF DOCETAXEL PLUS TRASTUZUMAB VERSUS ADO-TRASTUZUMAB EMTANSINE FOR RECURRENT, METASTATIC, OR TREATMENT-NAÏVE, UNRESECTABLE HER2-POSITIVE SALIVARY GLAND CANCER
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
